Get started
Author

Brad J. Hogan

Observed names: Brad Hogan, Brad J Hogan
OpenAlex ID: A5047524680
Live-cell phenotypic-biomarker microfluidic assay for the risk stratification of cancer patients via machine learning
2018 · Michael S. Manak, Jonathan S. Varsanik, et al. · Nature Biomedical Engineering · 79
Genomic predictors of interindividual differences in response to DNA damaging agents
2008 · Rebecca C. Fry, J. Peter Svensson, et al. · Genes & Development · 75
PDF
A simple and sensitive erythroblast scoring system to identify fetal cells in maternal blood
2003 · Donghyun Cha, Brad Hogan, et al. · Prenatal Diagnosis · 11
Rapid and Short-term Extracellular Matrix-mediated In Vitro Culturing of Tumor and Nontumor Human Primary Prostate Cells From Fresh Radical Prostatectomy Tissue
2017 · Ashok C. Chander, Michael S. Manak, et al. · Urology · 3
Application of Artificial Intelligence/Machine Vision & Learning for the Development of a Live Single-cell Phenotypic Biomarker Test to Predict Prostate Cancer Tumor Aggressiveness.
2020 · Jonathan S Varsanik, Michael S Manak, et al. · PubMed Central · 2
Mp07-17 Clinical Validation of a Live-cell Phenotypic Biomarker - Based Diagnostic Assay for the Prediction of Adverse Pathology in Prostate Cancer
2016 · David Albala, Vladimir Mouraviev, et al. · The Journal of Urology · 1
PDF
A live cell microfluidics device utilizing phenotypic biomarkers for prostate cancer.
2016 · David Albala, Vladimir Mouraviev, et al. · Journal of Clinical Oncology · 1
Abstract A31: Risk stratification of ductal carcinoma in situ: Analytical validation of a prognostic test analyzing live-primary cells via phenotypic biomarkers and machine learning at single-cell resolution
2018 · Ashok Chander, Michael Manak, et al. · Molecular Cancer Research
A novel live cell platform diagnostic utilizing phenotypic biomarkers for assessing prostate cancer aggressiveness.
2016 · Kevin B. Knopf, Kimberly M. Rieger-Christ, et al. · Journal of Clinical Oncology
Abstract 4347: A novel live cell diagnostic platform measuring phenotypic biomarkers using objective algorithmic analysis enables further risk stratification for intermediate-risk prostate cancer patients
2015 · Michael S. Manak, Wendell R. Su, et al. · Cancer Research
A novel live cell platform utilizing phenotypic biophysical and molecular biomarkers for assessing prostate cancer aggressiveness.
2015 · Kevin B. Knopf, Kimberly M. Rieger-Christ, et al. · Journal of Clinical Oncology
Mp1-19 a Novel Live Cell Microfluidic Diagnostic Using Phenotypic Biomarkers With Objective Algorithmic Analysis for Prostate Cancer Risk Stratification.
2015 · Kimberly Rieger-Christ, Travis Sullivan, et al. · The Journal of Urology
Novel live tumor cell diagnostic test utilizing biophysical and molecular biomarkers to assess local, advanced, and metastatic prostate cancer.
2015 · Kevin B. Knopf, Michael S. Manak, et al. · Journal of Clinical Oncology
Live cell in vitro prognostic utilizing biophysical and molecular biomarkers for measuring local growth and metastatic potential in prostate cancer.
2014 · Ashok C. Chander, Michael S. Manak, et al. · Journal of Clinical Oncology
Works count: 14
Citation count: 172
H-index: 3
I10-index: 3
Year
Topic
Type